glp-1 and anastrozole Receptor Agonists in Breast Cancer: 5 Key Clinical Takeaways GLP-1 Medications Infographic | Medidex
Description
GLP-1 RAs are currently being explored for use in various new areas, such as cardiovascular disease, non-alcoholic steatohepatitis (NASH), Alzheimer's disease, and chronic kidney disease
It can also lose lean muscle mass and bone density, which are critical for long-term strength and mobility
president, said in a statement
Tirzepatide in the context of autoimmune disease has its own considerations and potential benefits beyond weight loss
